Woodline Partners’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.1M | Buy |
3,445,871
+774
| +0% | +$2.04K | 0.05% | 449 |
|
|
2025
Q1 | $10.4M | Buy |
3,445,097
+2,657
| +0.1% | +$8K | 0.07% | 354 |
|
|
2024
Q4 | $8.81M | Buy |
3,442,440
+3,002,622
| +683% | +$7.69M | 0.06% | 375 |
|
|
2024
Q3 | $1.64M | Buy |
439,818
+1,975
| +0.5% | +$7.35K | 0.01% | 484 |
|
|
2024
Q2 | $2.77M | Buy |
+437,843
| New | +$2.77M | 0.03% | 389 |
|